AFSANA ASHARAF MD
Prescription History 1114448784
Internal Medicine - Pulmonary Disease in Shreveport, LA
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for AFSANA ASHARAF MD, an active Pulmonary Disease specialist practicing in Shreveport, LA. Our medical registry currently tracks 16 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 338 documented patient claims. Among these therapy options, the most frequently utilized medication is Trelegy Ellipta, which accounts for 39 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other LA PrescribersVs. LA Avg |
|---|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 39 | $903.04 | ▼ Less than typical |
About Trelegy Ellipta: This product is used to control and prevent symptoms (such as wheezing and shortness of breath) caused by asthma and ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Show more ▾ Controlling symptoms of breathing problems helps you stay active. This inhaler contains 3 medications: fluticasone, umeclidinium, and vilanterol. Fluticasone belongs to a class of drugs known as corticosteroids. It works by reducing swelling of the airways in the lungs to make breathing easier. Umeclidinium belongs to a class of drugs known as anticholinergics and vilanterol is a LABA medication. Both drugs work by relaxing the muscles around the airways so that they open up and you can breathe more easily. Both drugs are also known as bronchodilators. When used alone, long-acting beta agonists (such as vilanterol) may rarely increase the risk of serious (sometimes fatal) asthma-related breathing problems. However, combination products containing both an inhaled corticosteroid and long-acting beta agonist, such as this product, do not increase the risk of serious asthma-related breathing problems. For asthma treatment, this product should be used when breathing problems are not well controlled with two asthma-control medications (such as inhaled corticosteroid and long-acting beta agonist) or if your symptoms need combination treatment. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden shortness of breath. If sudden breathing problems occur, use your quick-relief inhaler as prescribed. In 2024, this provider wrote 39 Medicare prescriptions for Trelegy Ellipta, about 62% of the volume of the typical Louisiana prescriber of this medication (63.4). Medicare paid an average of $903.04 per fill, versus $808.59 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average LA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 55 30-Day Fills standardized to 30-day supplies 1,650 Days of Medication total across all patients in 2024 | |||
| OpsumitMacitentan | 35 | $13,203.87 | ≈ Typical |
About Opsumit: Macitentan is used to treat high blood pressure in the lungs (pulmonary arterial hypertension). Show more ▾ This condition is thought to be caused by increased levels of a certain natural substance (endothelin-1). This medication blocks the effects of endothelin-1, which helps decrease the blood pressure in the lungs, and reduces the risk of worsening of symptoms and hospital stays due to the disease. In 2024, this provider wrote 35 Medicare prescriptions for Opsumit, about 87% of the volume of the typical Louisiana prescriber of this medication (40.1). Medicare paid an average of $13,203.87 per fill, versus $12,673.57 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average LA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 35 30-Day Fills standardized to 30-day supplies 1,050 Days of Medication total across all patients in 2024 | |||
| OfevNintedanib Esylate | 29 | $12,984.74▼ below LA avg | ≈ Typical |
About Ofev: This medication is used to treat certain types of lung disease (idiopathic pulmonary fibrosis- IPF, interstitial lung disease). Show more ▾ Both types of lung disease scar and stiffen your lungs, making it hard to breathe. Nintedanib may help slow down the worsening of your lung disease. In 2024, this provider wrote 29 Medicare prescriptions for Ofev, about the same volume as the typical Louisiana prescriber of this medication (27.4). Medicare paid an average of $12,984.74 per fill, versus $13,021.07 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average LA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the LA average for this medication. 29 30-Day Fills standardized to 30-day supplies 855 Days of Medication total across all patients in 2024 | |||
| Mycophenolate Mofetil | 28 | $114.43 | ▼ Less than typical |
About Mycophenolate Mofetil: Mycophenolate is used in combination with other medications to keep your body from attacking and rejecting your transplanted organ (such as kidney, liver, heart). Show more ▾ It belongs to a class of medications called immunosuppressants. It works by weakening your body's defense system (immune system) to help your body accept the new organ as if it were your own. Compound derived from Penicillium stoloniferum and related species. It blocks de novo biosynthesis of purine nucleotides by inhibition of the enzyme inosine monophosphate dehydrogenase (IMP DEHYDROGENASE). Mycophenolic acid exerts selective effects on the immune system in which it prevents the proliferation of T-CELLS, LYMPHOCYTES, and the formation of antibodies from B-CELLS. It may also inhibit recruitment of LEUKOCYTES to sites of INFLAMMATION. In 2024, this provider wrote 28 Medicare prescriptions for Mycophenolate Mofetil, about 68% of the volume of the typical Louisiana prescriber of this medication (41.1). Medicare paid an average of $114.43 per fill, versus $103.64 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average LA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 41 30-Day Fills standardized to 30-day supplies 1,200 Days of Medication total across all patients in 2024 | |||
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 28 | $145.69▼ below LA avg | ≈ Typical |
About Fluticasone-Salmeterol: This product is used to control and prevent symptoms (wheezing and shortness of breath) caused by asthma or ongoing lung disease (chronic obstructive pulmonary disease-COPD, which includes chronic bronchitis and emphysema). Show more ▾ It contains 2 medications: fluticasone and salmeterol. Fluticasone belongs to a class of drugs known as corticosteroids. It works by reducing the irritation and swelling of the airways. Salmeterol belongs to the class of drugs known as long-acting beta agonists. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. When used alone, long-acting beta agonists (such as salmeterol) may rarely increase the risk of serious (sometimes fatal) asthma-related breathing problems. However, combination inhaled corticosteroid and long-acting beta agonists, such as this product, do not increase the risk of serious asthma-related breathing problems. For asthma treatment, this product should be used when breathing problems are not well controlled with one asthma-control medication (such as inhaled corticosteroid) or if your symptoms need combination treatment. Before using this medication, it is important to learn how to use it properly. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks. If an asthma attack occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. A drug combination of fluticasone and salmeterol that is used as an inhaler formulation to manage the symptoms of ASTHMA and CHRONIC OBSTRUCTIVE PULMONARY DISEASE. In 2024, this provider wrote 28 Medicare prescriptions for Fluticasone-Salmeterol, about the same volume as the typical Louisiana prescriber of this medication (24.7). Medicare paid an average of $145.69 per fill, versus $158.13 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average LA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the LA average for this medication. 40 30-Day Fills standardized to 30-day supplies 1,200 Days of Medication total across all patients in 2024 | |||
| Potassium Chloride | 25 | $9.61▼ below LA avg | ▼ Less than typical |
About Potassium Chloride: This medication is a mineral supplement used to treat or prevent low amounts of potassium in the blood. Show more ▾ A normal level of potassium in the blood is important. Potassium helps your cells, kidneys, heart, muscles, and nerves work properly. Most people get enough potassium by eating a well-balanced diet. Some conditions that can lower your body's potassium level include severe prolonged diarrhea and vomiting, hormone problems such as hyperaldosteronism, or treatment with "water pills"/diuretics. A white crystal or crystalline powder used in BUFFERS; FERTILIZERS; and EXPLOSIVES. It can be used to replenish ELECTROLYTES and restore WATER-ELECTROLYTE BALANCE in treating HYPOKALEMIA. In 2024, this provider wrote 25 Medicare prescriptions for Potassium Chloride, about a third of the volume of the typical Louisiana prescriber of this medication (85). Medicare paid an average of $9.61 per fill, versus $16.08 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average LA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the LA average for this medication. 31 30-Day Fills standardized to 30-day supplies 915 Days of Medication total across all patients in 2024 | |||
| Azithromycin | 22 | $30.41 | ▼ Less than typical |
About Azithromycin: Azithromycin is used to treat a wide variety of bacterial infections. Show more ▾ It is a macrolide-type antibiotic. It works by stopping the growth of bacteria. This medication will not work for viral infections (such as common cold, flu). Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness. A semi-synthetic macrolide antibiotic structurally related to ERYTHROMYCIN. It has been used in the treatment of Mycobacterium avium intracellulare infections, toxoplasmosis, and cryptosporidiosis. In 2024, this provider wrote 22 Medicare prescriptions for Azithromycin, about half the volume of the typical Louisiana prescriber of this medication (39.7). Medicare paid an average of $30.41 per fill, versus $5.13 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average LA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 45.7 30-Day Fills standardized to 30-day supplies 1,351 Days of Medication total across all patients in 2024 | |||
| Fluticasone Propionate | 18 | $11.45▼ below LA avg | ▼ Less than typical |
About Fluticasone Propionate: Fluticasone is used to relieve seasonal and year-round allergic and non-allergic nasal symptoms, such as stuffy/runny nose, itching, and sneezing. Show more ▾ It can also help relieve allergy eye symptoms such as itchy, watery eyes. This medication belongs to a class of drugs known as corticosteroids. It works in your nose to block the effects of substances that cause allergies (such as pollen, pet dander, dust mites, mold) and to reduce swelling. A STEROID with GLUCOCORTICOID RECEPTOR activity that is used to manage the symptoms of ASTHMA; ALLERGIC RHINITIS, and ATOPIC DERMATITIS. In 2024, this provider wrote 18 Medicare prescriptions for Fluticasone Propionate, about a quarter of the volume of the typical Louisiana prescriber of this medication (64.5). Medicare paid an average of $11.45 per fill, versus $13.16 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average LA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the LA average for this medication. 32.3 30-Day Fills standardized to 30-day supplies 970 Days of Medication total across all patients in 2024 | |||
| TrikaftaElexacaftor/Tezacaftor/Ivacaft | 17 | $25,776.72▼ below LA avg | ▼ Less than typical |
About Trikafta: This product has 2 different tablets. Show more ▾ One tablet contains 3 medications (it is a "multi-drug"): elexacaftor, tezacaftor, and ivacaftor. The other tablet contains only ivacaftor. This product is used to treat cystic fibrosis in certain people (those with an abnormal "CFTR" gene). It may help to improve breathing, reduce the risk of lung infections, and improve weight gain. In 2024, this provider wrote 17 Medicare prescriptions for Trikafta, about a quarter of the volume of the typical Louisiana prescriber of this medication (61.6). Medicare paid an average of $25,776.72 per fill, versus $26,924.89 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average LA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the LA average for this medication. 17 30-Day Fills standardized to 30-day supplies 476 Days of Medication total across all patients in 2024 | |||
| UptraviSelexipag | 17 | $30,415.16 | ▼ Less than typical |
About Uptravi: Selexipag is used to treat high blood pressure in the lungs (pulmonary arterial hypertension-PAH). Show more ▾ It is used to help slow down worsening of PAH and to decrease the chance of needing treatment in a hospital. Selexipag works by making it easier for blood to flow through the arteries in your lungs. This effect helps increase your ability to exercise. Prostacyclin receptor agonist. In 2024, this provider wrote 17 Medicare prescriptions for Uptravi, about 66% of the volume of the typical Louisiana prescriber of this medication (25.8). Medicare paid an average of $30,415.16 per fill, versus $22,930.81 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average LA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 17 30-Day Fills standardized to 30-day supplies 506 Days of Medication total across all patients in 2024 | |||
| Furosemide | 16 | $3.72▼ below LA avg | ▼ Less than typical |
About Furosemide: Furosemide is used to reduce extra fluid in the body (edema) caused by conditions such as heart failure, liver disease, and kidney disease. Show more ▾ This can lessen symptoms such as shortness of breath and swelling in your arms, legs, and abdomen. This drug is also used to treat high blood pressure. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Furosemide is a "water pill" (diuretic) that causes you to make more urine. This helps your body get rid of extra water and salt. A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY. In 2024, this provider wrote 16 Medicare prescriptions for Furosemide, about 17% of the volume of the typical Louisiana prescriber of this medication (96.4). Medicare paid an average of $3.72 per fill, versus $4.24 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average LA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the LA average for this medication. 20 30-Day Fills standardized to 30-day supplies 600 Days of Medication total across all patients in 2024 | |||
| Montelukast Sodium | 15 | $8.12▼ below LA avg | ▼ Less than typical |
About Montelukast Sodium: Montelukast is used to control and prevent symptoms caused by asthma (such as wheezing and shortness of breath). Show more ▾ It is also used before exercise to prevent breathing problems during exercise (bronchospasm). This medication can help decrease the number of times you need to use your quick relief inhaler. Montelukast is also used to relieve symptoms of hay fever and allergic rhinitis (such as sneezing, stuffy/runny/itchy nose). Since there are other allergy medications that may be safer (see also Warning section), this medication should be used for this condition only when you cannot take other allergy medications or they do not work well. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden asthma attacks or breathing problems. If an asthma attack or sudden shortness of breath occurs, use your quick-relief inhaler as prescribed. This drug works by blocking certain natural substances (leukotrienes) that may cause or worsen asthma and allergies. It helps make breathing easier by reducing swelling (inflammation) in the airways. A leukotriene D4 receptor antagonist. In 2024, this provider wrote 15 Medicare prescriptions for Montelukast Sodium, about 20% of the volume of the typical Louisiana prescriber of this medication (75.8). Medicare paid an average of $8.12 per fill, versus $9.23 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average LA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the LA average for this medication. 23 30-Day Fills standardized to 30-day supplies 670 Days of Medication total across all patients in 2024 | |||
| Tadalafil | 14 | $49.34▼ below LA avg | ▼ Less than typical |
About Tadalafil: Tadalafil is used to treat male sexual function problems (impotence or erectile dysfunction-ED). Show more ▾ In combination with sexual stimulation, tadalafil works by increasing blood flow to the penis to help a man get and keep an erection. Tadalafil is also used to treat the symptoms of an enlarged prostate (benign prostatic hyperplasia-BPH). It helps to relieve symptoms of BPH such as difficulty in beginning the flow of urine, weak stream, and the need to urinate often or urgently (including during the middle of the night). Tadalafil is thought to work by relaxing the smooth muscle in the prostate and bladder. This drug does not protect against sexually transmitted diseases (such as HIV, hepatitis B, gonorrhea, syphilis). Practice "safe sex" such as using latex condoms. Consult your doctor or pharmacist for more details. A carboline derivative and PHOSPHODIESTERASE 5 INHIBITOR that is used primarily to treat ERECTILE DYSFUNCTION; BENIGN PROSTATIC HYPERPLASIA and PRIMARY PULMONARY HYPERTENSION. In 2024, this provider wrote 14 Medicare prescriptions for Tadalafil, about half the volume of the typical Louisiana prescriber of this medication (27.6). Medicare paid an average of $49.34 per fill, versus $263.15 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average LA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the LA average for this medication. 14 30-Day Fills standardized to 30-day supplies 420 Days of Medication total across all patients in 2024 | |||
| Albuterol Sulfate HfaAlbuterol Sulfate | 12 | $44.98 | ▼ Less than typical |
About Albuterol Sulfate Hfa: Albuterol (also known as salbutamol) is used to prevent and treat wheezing and shortness of breath caused by breathing problems (such as asthma, chronic obstructive pulmonary disease). Show more ▾ It is also used to prevent asthma brought on by exercise. It is a quick-relief drug. Albuterol belongs to a class of drugs known as bronchodilators. It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Controlling symptoms of breathing problems can decrease time lost from work or school. A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol. In 2024, this provider wrote 12 Medicare prescriptions for Albuterol Sulfate Hfa, about 17% of the volume of the typical Louisiana prescriber of this medication (68.8). Medicare paid an average of $44.98 per fill, versus $30.08 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average LA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 17.9 30-Day Fills standardized to 30-day supplies 513 Days of Medication total across all patients in 2024 | |||
| Tiotropium Bromide | 12 | $385.96▼ below LA avg | ≈ Typical |
About Tiotropium Bromide: Tiotropium is used to control and prevent symptoms (such as wheezing, shortness of breath) caused by ongoing lung disease (chronic obstructive pulmonary disease-COPD which includes bronchitis and emphysema). Show more ▾ It works by relaxing the muscles around the airways so that they open up and you can breathe more easily. Tiotropium belongs to a class of drugs known as anticholinergics. Controlling symptoms of breathing problems can decrease time lost from work or school. This medication must be used regularly to be effective. It does not work right away and should not be used to relieve sudden breathing problems. If wheezing or sudden shortness of breath occurs, use your quick-relief inhaler (such as albuterol, also called salbutamol in some countries) as prescribed. A scopolamine derivative and CHOLINERGIC ANTAGONIST that functions as a BRONCHODILATOR AGENT. It is used in the treatment of CHRONIC OBSTRUCTIVE PULMONARY DISEASE. In 2024, this provider wrote 12 Medicare prescriptions for Tiotropium Bromide, about 87% of the volume of the typical Louisiana prescriber of this medication (13.7). Medicare paid an average of $385.96 per fill, versus $423.58 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average LA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the LA average for this medication. 12 30-Day Fills standardized to 30-day supplies 360 Days of Medication total across all patients in 2024 | |||
| Pantoprazole Sodium | 11 | $3.94▼ below LA avg | ▼ Less than typical |
About Pantoprazole Sodium: Pantoprazole is used to treat certain stomach and esophagus problems (such as acid reflux). Show more ▾ It works by decreasing the amount of acid your stomach makes. This medication relieves symptoms such as heartburn, difficulty swallowing, and cough. It helps heal acid damage to the stomach and esophagus, helps prevent ulcers, and may help prevent cancer of the esophagus. Pantoprazole belongs to a class of drugs known as proton pump inhibitors (PPIs). 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER. In 2024, this provider wrote 11 Medicare prescriptions for Pantoprazole Sodium, about 9% of the volume of the typical Louisiana prescriber of this medication (118). Medicare paid an average of $3.94 per fill, versus $11.00 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average LA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the LA average for this medication. 15 30-Day Fills standardized to 30-day supplies 450 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for AFSANA ASHARAF MD is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Pulmonary Disease prescribing approach at this Shreveport, LA practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among LA prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
